Registry of Lobbyists
Version 1 of 2 (2005-08-22 to 2006-03-08) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
ID BIOMEDICAL CORPORATION
525 Cartier West Laval, QC H7V 3S8 Canada |
| Telephone number: | 450-978-6301 |
| Fax number: | 450-978-7956 |
| Responsible officer name and position during the period of this registration: | Anthony Holler, CEO |
| Description of activities: | ID Biomedical Corporation is an integrated biotechnology company dedicated to the development of innovative vaccine products. It operates in research, development, manufacturing, sales and marketing from its facilities in Canada and in the United States. |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | MUSTAPHA BAKALI |
| Position title: | CHIEF OPERATING OFFICER |
| Public offices held: | No |
| Name: | IRENE CLEMENT |
| Position title: | VICE PRESIDENT REGULATORY AFFAIRS |
| Public offices held: | No |
| Name: | ANTHONY HOLLER |
| Position title: | CHIEF EXECUTIVE OFFICER |
| Public offices held: | No |
| Name: | RABIH KYRIAKOS |
| Position title: | ASSOCIATE DIRECTOR, SALES AND MARKETING |
| Public offices held: | No |
| Name: | TERESA MCCRORY |
| Position title: | DIRECTOR OF FINANCE |
| Public offices held: | No |
| Name: | LAZLO PALKONYAY |
| Position title: | VICE PRESIDENT GOVERNMENTAL AFFAIRS |
| Public offices held: | Yes |
| Name: | TODD PATRICK |
| Position title: | PRESIDENT |
| Public offices held: | No |
| Name: | MICHELE ROY |
| Position title: | VICE PRESIDENT CORPORATE COMMUNICATIONS |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, Public Works and Government Services Canada, Treasury Board Of Canada Secretariat (TBS) | ||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||
| Subject Matter: Areas of Concern: | Government Procurement, Health, Industry, Internal Trade, Science and Technology, Taxation and Finance | ||||
| Subject Matter: Retrospective: | The company deals on a regular basis with Public Office Holders of the Canadian Government working for the following Governmental Deparments: Industry Canada, Health Canada, Public Works Government Canada Services, BGTD.The company is party to Canadian Government Funding Agreements under the Technology Partnership Canada. The company is also supplier to the Canadian Government and the Provinces of two vaccines, including 75% of Canada's need for an Influenza Vaccine. | ||||
| Subject Matter: Prospective: | It is now part of the public domain that the company is negotiating with Public Office Holders at Health Canada and Public Works Government Canada Services with regards to Government Funding to fund the construction, engineering equipment and validation of a new pilot plant laboratory in the company's Ste-Foy, Province of Quebec manufacturing facility and the conduct of clinical trials in Canada of a mock pandemic avian flu vaccine. Details of these negotiations and communications are confidential. | ||||
Details Regarding the Identified Subject Matter
|
|||||